Genetic Testing Company | The DNA Diagnostic Experts | GeneDx

In observance of Independence Day, GeneDx will be closed on Friday, July 3rd, and Saturday, July 4th. Nevertheless, all specimens arriving on Friday, July 3rd will be accepted, accessioned and processed. We will not accept specimens on Saturday, July 4th. We will resume our normal Monday through Saturday schedule on Monday, July 6, 2015. Please also note that FedEx works on a modified schedule on Friday, July 3rd and FedEx and UPS are closed on Saturday, July 4th. If you have any questions or inquiries, please call us at 301-519-2100 or email us at zebras@genedx.com.

CNGA1 Gene Sequencing

FORMS AND DOCUMENTS

TEST DETAILS

Genes:
CNGA1
Disorders:
Clinical Utility:
  • Confirmation of a clinical diagnosis
  • To differentiate ARRP, adRP, and X-linked RP from other forms of retinal dystrophy and retinal degeneration
  • Recurrence risk assessment
  • Prenatal diagnosis
Lab Method:
Capillary Sequencing

ORDERING

Test Code:
417
Turnaround Time:
6-7 weeks
Preferred Specimen:
2-5 mL Blood - Lavender Top Tube
Alternative Specimen:
Oral Rinse (30-40 mL), Dried Blood Spots

BILLING

CPT Codes:
81479x1
New York Approved:
No
ABN Required:
Yes
Billing Information:
View Billing Policy
ICD Codes:
  • 362.74: Pigmentary retinal dystrophy, Retinal dystrophy, albipunctate, Retinitis pigmentosa
  • 743.55: Congenital macular changes
  • 743.53: Chorioretinal degeneration, congenital
  • 743.54: Congenital folds and cysts of posterior segment
  • 362.76: Dystrophies primarily involving the retinal pigment epithelium, Fundus flavimaculatus, Vitelliform dystrophy
  • 362.75: Other dystrophies
  • 743.56: Other retinal changes, congenital
* For price inquiries please email zebras@genedx.com

REFERENCES

  1. Danciger M et al., (1996) Mol Vis 2:10
  2. den Hollander et al., (1999) Nat Genet 23:217–221
  3. den Hollander et al., (2001) Am J Hum Genet 69:198–203
  4. den Hollander et al., (2004) Hum Mutat 24:355-69
  5. Dreyer B et al., (2001) Am J Hum Genet 69:228-34
  6. Dreyer B et al., (2008) Hum Mutat 29:451
  7. Hanein S et al., (2004) Hum Mutat 23:306-17
  8. Huang SH et al., (1995) Nat Genet 11:468-71
  9. Lotery et al., (2001) Ophthalmic Genet 22:163-9
  10. McLaughlin ME et al., (1993) Nat Genet 4:130-4
  11. McLaughlin ME et al., (1995) Proc Natl Acad Sci 11;92:3249-53
  12. Morimura H et al., (1998) Proc Natl Acad Sci 95:3088–3093
  13. Pieke Dahl S et al., (1996 ) J Med Genet 33:753-7
  14. Rivolta C et al., (2000) Am J Hum Genet 66:1975–78
  15. Sandberg MA et al., (2008) Invest Ophthalmol Vis Sci 49:5532-9
  16. Seyedahmadi et al, (2004) Exp Eye Res 79:167-73
  17. Stone E (2007) Am J Ophthalmol 144:791-811
  18. Valverde D et al., (1996) Hum Mutat 8(4):393-4
  19. Weston et al., 2000 Am J Hum Genet 66:1199-210
  20. Wiszniewski W et al., (2005) Hum Mol Genet 1;14:2769-78
  21. Dryja et al., (1995) Proc. Natl Acad Sci 92:10177-10181
  22. Zhang et al., (2004) Mol Vis 10:884-889
  23. Paloma et al., (2002) J Med Genet 39:1-4
  24. Dryja TP et al., (1999) Invest Ophthalmol Vis Sci 40:1859-1865
  25. Danciger M et al., (1995) Genomics 1;30(1):1-7
  26. Collin RWJ (2009) ARVO meeting, May3-7, Fort Lauderdale, FL
  27. Collin RWJ et al., (2008) Am J Hum Genet 83:594-603
  28. Cremers FPM et al., (1998) Hum Molec Genet 7:355-362
  29. Booij JC (2005) J Med Genet 42:e67
  30. Bo Dreyer (2008) Hum Mutat 29:451
  31. Bernal S et al., (2003) J Med Genet 40:e89
  32. Bennett S et al., (2004) Pharmacogenomics 5:433-8
  33. Allikmets et al., (1998) Gene 215: 111- 122
  34. Abd El-Aziz MM et al., (2008) Nat Genet 40:1285-7
  35. Abd El-Aziz MM et al., (2007) Ann Hum Genet 71:281-94

Back To Top